Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Aug 15, 2026; 18(8): 120985
Published online Aug 15, 2026. doi: 10.4251/wjgo.v18.i8.120985
Published online Aug 15, 2026. doi: 10.4251/wjgo.v18.i8.120985
Table 1 Comparison of general characteristics between the two groups, n (%)/mean ± SD
| Indicator | Diminished ovarian reserve group (n = 50) | Normal ovarian reserve group (n = 60) | χ2/t | P value |
| Age, years | 0.478 | 0.489 | ||
| < 35 | 16 (32.00) | 23 (38.33) | ||
| ≥ 35 | 34 (68.00) | 37 (61.67) | ||
| BMI (kg/m2) | 23.26 ± 2.17 | 23.54 ± 2.36 | 0.638 | 0.525 |
| Menarche age, years | 12.94 ± 2.56 | 13.28 ± 2.55 | 0.703 | 0.484 |
| Gravidity, times | 1.28 ± 0.70 | 1.53 ± 0.70 | 1.888 | 0.062 |
| Menstrual cycle, days | 30.30 ± 1.63 | 29.88 ± 2.10 | -1.144 | 0.255 |
| History of ovarian surgery | - | 0.687 | ||
| No | 47 (94.00) | 56 (93.33) | ||
| Yes | 3 (6.00) | 4 (6.67) | ||
| Disease duration, years | 2.12 ± 0.44 | 2.22 ± 0.52 | 1.057 | 0.293 |
| Tumor diameter, cm | 2.98 ± 0.57 | 3.06 ± 0.80 | 0.629 | 0.531 |
| Type of chemotherapy | 0.178 | 0.673 | ||
| Non platinum containing scheme | 10 (20.00) | 14 (23.33) | ||
| Platinum containing scheme | 40 (80.00) | 46 (76.67) | ||
| Tumor staging | 0.079 | 0.779 | ||
| I-II | 27 (54.00) | 34 (56.67) | ||
| III-IV | 23 (46.00) | 26 (43.33) | ||
| Smoking or not | - | 0.753 | ||
| No | 46 (92.00) | 54 (90.00) | ||
| Yes | 4 (8.00) | 6 (10.00) | ||
| Drinking or not | - | 0.726 | ||
| No | 47 (94.00) | 55 (91.67) | ||
| Yes | 3 (6.00) | 5 (8.33) |
Table 2 Comparison of uterine artery ultrasound hemodynamic parameters between the two groups after chemotherapy, n (%)/mean ± SD
| Group | n | PI | RI | PSV (cm/second) |
| Diminished ovarian reserve group | 50 | 2.56 ± 0.28 | 0.91 ± 0.06 | 33.62 ± 3.26 |
| Normal ovarian reserve group | 60 | 2.28 ± 0.36 | 0.83 ± 0.11 | 37.45 ± 3.29 |
| t value | -4.469 | -5.061 | 6.101 | |
| P value | < 0.001 | < 0.001 | < 0.001 |
Table 3 Comparison of follicle-stimulating hormone and anti-Müllerian hormone levels between the two groups after chemotherapy (mean ± SD)
| Group | n | FSH (mIU/mL) | AMH (ng/mL) |
| Diminished ovarian reserve group | 50 | 10.27 ± 2.95 | 1.92 ± 0.24 |
| Normal ovarian reserve group | 60 | 8.20 ± 2.13 | 3.29 ± 1.18 |
| t value | -4.128 | 8.798 | |
| P value | < 0.001 | < 0.001 |
Table 4 Predictive value of uterine artery ultrasound hemodynamic parameters, follicle-stimulating hormone and anti-Müllerian hormone levels for diminished ovarian reserve function
| Indicator | AUC | P value | Sensitivity (%) | Specificity (%) | Accuracy (%) | 95%CI |
| PI | 0.726 | < 0.001 | 0.88 (44/50) | 0.50 (30/60) | 67.27 (74/110) | 0.632-0.819 |
| RI | 0.733 | < 0.001 | 0.90 (45/50) | 0.52 (31/60) | 69.09 (76/110) | 0.640-0.825 |
| PSV | 0.791 | < 0.001 | 0.92 (46/50) | 0.52 (31/60) | 70.00 (77/110) | 0.708-0.873 |
| FSH | 0.723 | < 0.001 | 0.62 (31/50) | 0.82 (49/60) | 72.73 (80/110) | 0.622-0.824 |
| AMH | 0.895 | < 0.001 | 0.94 (47/50) | 0.85 (51/60) | 89.09 (98/110) | 0.823-0.966 |
| Combined detection | 0.950 | < 0.001 | 0.94 (47/50) | 0.90 (54/60) | 91.82 (101/110) | 0.911-0.989 |
- Citation: Chen CY, Tan LL, Zhang JY, Zhang YP. Association of uterine artery Doppler, follicle-stimulating hormone, and anti-Müllerian hormone with post-chemotherapy ovarian reserve in reproductive-age colorectal cancer patients. World J Gastrointest Oncol 2026; 18(8): 120985
- URL: https://www.wjgnet.com/1948-5204/full/v18/i8/120985.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v18.i8.120985